Imperative secures $100M for thromboembolic technologies

AI Briefing

• – Imperative Care Inc. secures $100M for thromboembolic technologies through oversubscribed convertible note financing round.
• – The round was co-led by Elevage Medical Technologies and Perceptive Advisors alongside existing investors.
• – Participating investors include Longaeva Partners LP, Brown Advisory, Ally Bridge Group, and Bain Capital Life Sciences.